← SynDRA
ROCILETINIB
SynDRA canonical compound SYN0038268 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | EGFR |
| Mechanism of action | EGFR inhibitor |
All known targets
Mechanisms of action (all sources)
- EGFR INHIBITOR
- Epidermal growth factor receptor erbB1 inhibitor
- EGFR MODULATOR
ATC classes
- L01E · PROTEIN KINASE INHIBITORS
Cross-references
Synonyms
- 8JC
- AVL-301
- CNX-419
- CO-1686
- CS-1631
- ROCILETINIB (CO-1686)
- ROCILETINIB HYDROBROMIDE
- CO 1686
- CO1686
- UNII-72AH61702G
- CO-1686 (AVL-301)
- Rociletinib(AVL-301,CNX-419,CO-1686)
- 72AH61702G
- N-(3-((2-((4-(4-acetylpiperazin-1-yl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)acrylamide
- Rociletinib (CO-1686, AVL-301)
- Rociletinib [USAN:INN]
- Tube721
- Rociletinib (USAN/INN)
- Rociletinib (CO-1686)
- SCHEMBL4177736
- GTPL7966
- CHEMBL3545308
- EX-A228
- MolPort-035-395-816
- C27H28F3N7O3
- HMS3653G08
- BDBM149404
- BCP07085
- AOB87314
- ZINC98043800
- s7284
- N-(3-((2-((4-(4-Acetylpiperazin-1-yl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)prop-2-enamide
- N-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide
- N-(3-{[2-{[4-(4-Acetylpiperazin-1-yl)-2-methoxyphenyl]amino}-5-(trifluoromethyl)pyrimidin-4-yl]amino}phenyl)prop-2-enamide
- Rociletinib [USAN]
- ROCILETINIB [INN]
- CO-1686(Rociletinib)
- Rociletinib; CO-1686
Look up ROCILETINIB in the interactive SynDRA portal →